Aggregated price index with volume information
Summary:
- The momentum of the sector is very strong.
- Alzheimer Treatment stocks up 0.3% on average while median return up -0.6% in a day
- Alzheimer Treatment stocks up 9.3% on average while median return up 4.7% in a week
- Alzheimer Treatment stocks up 14.8% on average while median return up 6.0% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $ANVS 61.7%, $CYTH 35.6%, $AVXL 31.6%, $ACIU 28.7%, $WVE 11.5%
- 1M losers are : Losers for past month are $SAVA -6.2%, $ACAD -7.4%, $DNLI -15.1%
- 1W winners are : Winners for past week are $ANVS 36.4%, $WVE 22.9%, $ATHA 21.9%, $AVXL 17.3%, $ACIU 9.4%
- 1W losers are : Losers for past week are
Correlation Analysis
Index correlation analysis
Correlation for the past month is 24.8%, for the past 3 months is 19.4%
In the past month for a 5 days rolling window, the highest corrrelation is 41.4%, the lowest correlation is 8.7%, the latest correlation is 9.1%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 82.4% between DNLI and VYGR
The lowest correlation is -38.6% between ANVS and CYTH
In this article, we discuss 12 best healthcare dividend stocks to buy now. You can skip our detailed analysis of the healthcare sector and the past performance of dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks To Buy Now. Over the span of almost four years, the COVID-19 pandemic brought about […]
NEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December ...
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
AbbVie Inc. (NYSE: ABBV) and BigHat Biosciences, today announced a research collaboration to discover and develop next-generation therapeutic antibodies in oncology and neuroscience. Working closely with AbbVie, BigHat will utilize its Milliner™ platform, a suite of machine learning technologies integrated with a high-speed wet lab, to guide the design and selection for high quality antibodies for multiple therapeutic targets.
BERWYN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases today announced last patient last visit in the phase III study of its lead candidate buntanetap in patients with early Parkinson’s disease (PD). Topline data results are expected in January 2024. "We are pleased to share the completion of our Parkinson's study which marks a significant step forward in our ongoing mission t
In this article, we will look into the 25 states with the lowest life expectancy in the US. If you want to skip our detailed analysis, you can go directly to the 5 States with the Lowest Life Expectancy in the US. Health Outlook of the United States According to the OECD Health at a […]
Here, we discuss some reasons why investing in AC Immune (ACIU) stock now may turn out to be a prudent move.
Key Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price might be vulnerable...
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. After a robust first half of the year, the S&P 500 Index declined 3.3% in the third quarter, leaving the market up 13.1% through the first nine […]
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. After a robust first half of the year, the S&P 500 Index declined 3.3% in the third quarter, leaving the market up 13.1% through the first nine […]